Liraglutide for Weight Loss: Benefits, Dosage, and Side Effects in 2025
Liraglutide, sold under brand names such as Saxenda and Victoza, remains a trusted GLP-1 receptor agonist for weight loss and type 2 diabetes treatment. In 2025, it continues to serve patients seeking moderate, sustained weight reduction without invasive procedures.
How Liraglutide Works
Liraglutide activates GLP-1 receptors in the brain, which regulate appetite and satiety. It slows gastric emptying and enhances insulin secretion, supporting both glycemic control and reduced food intake.
Recommended Dosage
For weight management, patients typically start at 0.6 mg daily and titrate up to a maximum of 3.0 mg based on tolerance and physician guidance. Dosage escalation usually occurs weekly to reduce gastrointestinal side effects.
Common Side Effects
Mild side effects include nausea, diarrhea, and fatigue. These usually subside within the first few weeks. Serious risks like pancreatitis or thyroid C-cell tumors are rare but monitored in long-term users.
Is Liraglutide Still Effective in 2025?
Though newer GLP-1 agents like semaglutide and tirzepatide have entered the market, liraglutide maintains clinical relevance due to its once-daily dosing and insurance coverage. It remains a cost-effective alternative for patients who tolerate it well.
As always, consult a healthcare provider before starting any new treatment. Liraglutide continues to help thousands lose weight safely and sustainably in 2025.